In a citizen petition posted by the FDA this week, Novo urged the regulator to restrict the ability of compounding pharmacies ...

After plugging billions into its manufacturing network to meet rampant demand for Mounjaro and Zepbound, Eli Lilly is looking ...

Many compounding pharmacies make unbranded versions of semaglutide ... "If compounded semaglutide goes away as well, then I ...

A new request by Ozempic manufacturer Novo Nordisk could limit the availability of a type of GLP-1—semaglutides—to local ...

Many compounding pharmacies make unbranded versions of semaglutide ... She has launched an online petition demanding that the FDA support access to compounded GLP-1s. The petition has gained ...

I found that so many people were making their own GLP-1s and taking smaller amounts than normally prescribed,” she said. “I ...

The USA compounding pharmacies market is on track for significant growth, estimated to reach USD 5,156.2 million in 2024, ...

Bonello took to Change.org, creating an online petition urging the FDA ... the only way that I could take it was through compound pharmacies, because it was so expensive," Bonello said.

Novo Nordisk faces scrutiny over UK pharmacy sponsorships tied to weight-loss drugs, with critics citing conflicts of interest and regulatory breaches.

One of the biggest advantages of pharmacies is their accessibility. Located in neighborhoods and small towns, they provide an ...